Friday, May 24, 2019
News
NEWS HOME
»
PRESS RELEASES

SpeeDx and Cepheid Announce Test Partnership
  SocialTwist Tell-a-Friend  
   


Date: 16-04-2019 3:51PM
Source: SpeeDx
Category: General, Financial Analyst & Investors, Healthcare & Biotechnology, Pharmaceutical, Manufacturing Companies
Location: Sydney, Australia

Business Wire India

SpeeDx Pty, Ltd. announced an agreement with Cepheid to manufacture their market-leading ResistancePlus® tests for use on the GeneXpert System. The first test in Cepheid’s FleXible Cartridge programme, planned for launch early 2019, is ResistancePlus® MG, detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) and markers associated with azithromycin resistance.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190415005919/en/

ResistancePlus MG will be the first assay available through the Cepheid FleXible for GeneXpert progr ...

ResistancePlus MG will be the first assay available through the Cepheid FleXible for GeneXpert program.

“The availability of ResistancePlus MG in a FleXible cartridge that runs on the GeneXpert System is a compelling and exciting extension for us,” said Colin Denver, CEO of SpeeDx. “Patients are already benefiting from Resistance Guided Therapy with our central lab tests. Now clinicians can receive resistance information even faster, to support antimicrobial stewardship and more effective antibiotic treatment decisions.”

“Our new FleXible Cartridge program allows Trusted Reagent Manufacturers to develop targeted molecular tests using Cepheid’s easy-to use-cartridge.” said David H. Persing, M.D., Ph.D., Cepheid's Chief Medical and Technology Officer. “With a global installed base of nearly 22,000 GeneXpert Systems, this technology could potentially be applied in multiple settings in which actionable treatment information is needed quickly.”

Management guidelines for Mgen infection include resistance testing1-3 in response to rising rates of macrolide resistance observed with Mgen detection-only or empiric Mgen treatment.4-6 ResistancePlus® MG supports Mgen management guidelines and allows for Resistance Guided Therapy, which is clinically proven to improve cure rates by providing clinicians with much needed information to guide antibiotic treatment.3

About Mgen

M. genitalium can cause symptoms such as urethritis, cervicitis, endometritis and pelvic inflammatory disease. In recent studies, it has been found to have a higher prevalence than gonorrhea. 7 Like gonorrhea, M. genitalium is also evolving into a so-called STI superbug that is becoming resistant to many antibiotic treatments, leading to exceedingly difficult-to-treat infections and threatening global public health.8

Macrolide antibiotics, specifically azithromycin, are the first-line treatment for the rapidly growing problem of M. genitalium STIs, but resistance to these antibiotics has increased up to 50% in several countries.4-6 Due to this growing antibiotic resistance problem, several global STI Management Guidelines on Mgen Infections recommend complementing the use of molecular testing to detect M. genitalium with an assay capable of detecting macrolide resistance-associated mutations.1-3

Currently, there is no FDA-cleared molecular diagnostic test for the detection of M. genitalium in the U.S. The SpeeDx ResistancePlus® MG assay is CE marked for sale in Europe and TGA approved for sale in Australia. The test provides valuable detection and antibiotic resistance information to clinicians in a rapid time frame. Timely detection of antibiotic resistant infections enables Resistance Guided Therapy for better treatment of the disease for patients, lessening the potential for spreading among vulnerable populations and combating antibiotic resistance.

About SpeeDx

Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease. For more information on SpeeDx please see: https://plexpcr.com

About Cepheid

Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.

1. Jensen JS, Cusini M, Gomberg M, Moi H. 2016. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. PMID: 27505296.
2. https://www.bashhguidelines.org/media/1146/ngu-update-05_2017-final.pdf
3. http://www.sti.guidelines.org.au/sexually-transmissible-infections/mycoplasma-genitalium
4. Read T R H, Fairley C K, Murray G L, et al. Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation, Clinical Infectious Diseases, ciy477, https://doi.org/10.1093/cid/ciy477
5. Getman D, Jiang A, O'Donnell M, Cohen S. 2016. Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J Clin Microbiol 54:2278-2283.
6. Murray GL, Bradshaw CS, Bissessor M, et al. Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium. Emerging Infectious Diseases. 2017;23(5):809-812. doi:10.3201/eid2305.161745.
7. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004; 291:2229–2236.
8. Unemo, M. & Jensen, J.S. ‘Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium’. 2016. Nat. Rev. Urol.268. Published online 10 Jan 2017. doi:10.1038/nrurol


MULTIMEDIA AVAILABLE :
https://www.businesswire.com/news/home/20190415005919/en/


CONTACTS :

SpeeDx:
Europe, Australia, New Zealand:
Madeline O’Donoghue
+61 2 9209 4170
madelineo@speedx.com.au

USA:
Rick Roose
+1 415.202.4445
roi.roose@gmail.com

Cepheid:
Darwa Peterson
darwa@cepheid.com
Tel. + 1.408.400.4324

More Press Releases

Get Your Home Loan From Bajaj Housing Finance Ltd at the Lowest Interest Rate

ITechLaw Publishes New Book and Opens Global Public Comment Period on Draft Principles for Responsible Artificial Intelligence

Audi China President Thomas Owsianski to Keynoteat CES Asia 2019

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 2019

Bacardi Limited Announces 5th Annual Good Spirited Awards for Employee-Led Global Environmental Sustainability Programs

Andersen Global Expands UK Locations

Secure Your Vacation Travel With Bajaj Finserv’s Affordable Pocket Insurance Products

OnePlus 7 Pro Becomes the Fastest Selling Ultra Premium Smartphone on Amazon.in

Corporate Social Responsibility Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets

Network of 1,500 Stroke-Ready Clinics across Europe

CSS Corp Wins The Golden Globe Tigers 2019 Awards From CMO Asia Group

Mary Kay Inc.’s David Holl Named Among Top Ten Most Reputable CEOs in the World, According to Reputation Institute

Secure-D Exposes Suspicious Android App with 500 Million Downloads

Taro Provides Results for the Year Ended March 31, 2019

The 26th HKTDC Hong Kong Fashion Week for Spring/Summer Opens in July

Lenovo Achieves Record Revenue for FY18/19 Driven by Success of Intelligent Transformation Strategy and Strong Operational Performance

Buy and Sell Globally: 2019 Yiwu Imported Commodities Fair Opens in “World’s Capital of Small Commodities”

Diligent Launches Modern Governance to Address Dangerous Governance Deficits and Announces New Modern Governance Summit

Groupe ADP Wins Many Overseas and International Contracts

New Fluid Dispensing Guide for Stock Lubrication and Metal Stamping from Nordson EFD

Wipro Builds a Blockchain-Based Solution for Travacoin to Enable Digital Currency-Based Payments for the Airline Industry

Exit CRM. Enter CXM

IIIT Hyderabad and TalentSprint Announce Pan India Roll out of Their Popular Executive Programs in AI/Machine Learning, Blockchain and DLT

INMA Reveals Global Media Awards Winners

Masala King Dr. Dhananjay Datar and Vandana Datar Honoured With International MahaBrand Award

Jefferies Establishes Global Microstrategy Research

NIPPON Platform Has Established the Ninth Overseas Branch "NIPPON Platform OÜ" in Estonia

Toshiba Starts Shipment of UL 508 Certified Photorelays for Industrial Control Equipment

TPL Delivers 28 percent Rise in Sales in Q4 at Rs. 331.71 Crores

Philip Morris International Strengthens Organizational Capabilities to Realize Its Vision for a Smoke-Free Future

PVH Corp. Names Stefan Larsson to Newly Created Role of President

Virgin Voyages Expands Epic Entertainment Lineup

Andersen Global Signs First Agreement in Bahrain

Sintavia Announces Joint Venture with Howco Group

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Congress wins 52 seats in LS polls...
Terrorist Zakir Musa killed in encounter...
BJP retains all seven seats in Delhi...
It's a new morning for Amethi: Smriti Ir...
Negative campaign against PM Modi boomer...
Trump congratulates Modi over election v...
More...    
 
 Top Stories
UN looks forward to working with Mo... 
Rains bring down mercury in Himacha... 
Smriti Irani thanks voters for Amet... 
India 2nd in government requests fo... 
PM Modi meets Advani... 
Modi's victory tribute to Vajpayee,... 
Party is over for Samajwadi family,... 
2 women dead in Mumbai building fir...